Aurobindo Pharma Limited (NSE:AUROPHARMA)

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 91.50B INR in the quarter ending June 30, 2026, with 16.30% growth. This brings the company's total for the last twelve months to 349.35B, up 9.09% year-over-year. In the fiscal year ending March 31, 2026, Aurobindo Pharma had annual revenue of 336.53B with 6.08% growth. That makes Aurobindo Pharma the 3,271st largest company in the world by revenue and 88th in India.

• Revenue (ttm): 349.35B
• Revenue Growth: +9.09%
• P/S Ratio: 2.65
• Revenue / Employee: 11.96M
• Employees: 29,209
• Market Cap: 904.49B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• USA 143.59B 42.7%
• Europe 106.88B 31.8%
• Rest of the World 52.78B 15.7%
• India 33.27B 9.9%

Fiscal year ended Mar 31, 2026 See the full Aurobindo Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	336.53B	19.29B	6.08%
Mar 31, 2025	317.24B	27.22B	9.39%
Mar 31, 2024	290.02B	41.46B	16.68%
Mar 31, 2023	248.55B	14.00B	5.97%
Mar 31, 2022	234.55B	-13.19B	-5.32%

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error